Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
400 participants
OBSERVATIONAL
2023-09-04
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to:
* Describe the mental health care trajectories of adolescents and young adults after an acute psychiatric episode.
* Identify psychiatric disorders (such as anxiety, depression, eating disorders, suicidal thoughts, sleep, etc.) at the different time points of the study (at 3, 6, 9 and 12 months after inclusion) ;
* Assess the quality of life and functional capacity in daily activities of participants at each study time point ;
* Determine the socio-demographic, psychosocial and environmental factors associated with improving mental health over time and with mental health help seeking.
Patients aged from 10 to 24, presenting to one of the participating centers for an acute psychiatric episode, and who agree to participate, will be included in the study. Participants will have to complete an online questionnaire every 3 months over a 12-month period (at baseline (T0), at 3 months (T3), at 6 months (T6), at 9 month (T9) and at 12 months (T12))
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Mental Disorders in Adolescents With Chronic Pain: Creation of a Screening Tool for Use by the General Practitioner
NCT04467229
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study
NCT02739932
Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psychiatric Disorders
NCT05866991
Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
NCT05930353
Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT
NCT07211750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A poster campaign will be carry out in all study locations. Patients aged between 10 and 25 visiting one of the study location will be invited to participate in the study. The clinical research associates will visit all study location on a weekly basis in order to present the study to eligible patients.
After checking the inclusion criteria, the clinical research associate will call eligible patients (or their legal representative for patients under 18) to present the study, the implications related to study participation, and obtain their oral consent. Patients who were willing to participate in the study will be automatically identify by a number.
Follow-up :
Patients will have to complete an online questionnaire at different time of the study: at baseline, at 3 months, at 6 months, at 9 months and at 12 months. For the participants aged under 18, the questionnaire will have to complete by or with the help of the parental representative.
Investigators will collect socio-demographic, clinical data related to the acute psychiatric episode, and health care pathway over time. Mental health assessments will be based on standardized questionnaires.
Clinical research associates will send an email to all participants to complete the initial questionnaire (at baseline). Then, they will coordinate patient follow-up, and will send automatic reminder through email at the different times of the study :at 3 months (M3), 6 months (M6), 9 months (M9) and 12 months (M12) to complete the follow-up questionnaires online. Patients will be awarded a gift voucher worth €10 after each completed questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged from 10 to 24 years old
* had an consultation in one the study locations for psychiatric reason
Exclusion Criteria
* Adult patients under legal protection
* Lack of proficiency in French (language of the study)
10 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupement Interrégional de Recherche Clinique et d'Innovation
OTHER
Centre Hospitalier St Anne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle SABBAH-LIM, Pediatric psychiatrist
Role: PRINCIPAL_INVESTIGATOR
GHU Paris Psychiatrie et Neurosciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Emergency Department - Armand Trousseau Hospital
Paris, Île-de-France Region, France
ATRAP (Acute unit for child outpatients)
Paris, Île-de-France Region, France
C.P.O.A (Psychiatric Emergency Department)
Paris, Île-de-France Region, France
Pediatric Emergency Department - Necker Hospital
Paris, Île-de-France Region, France
CIAPA (Inpatient unit for Adolescents)
Paris, Île-de-France Region, France
Adult Emergency Department - Bichât Hospital
Paris, Île-de-France Region, France
Pediatric Emergency Department - Robert Debré Hospital
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Michel LEJOYEUX, Psychiatrist
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D22-EPI031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.